Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: A role for dual drug resistance?

被引：0

作者：

Lev, EI

Bray, PF

Patel, R

Delao, T

Granada, J

Kleiman, NS

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Methodist Hosp, Houston, TX 77030 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：86A / 86A

页数：1

共 50 条

[41] Communication of Potential Adverse Drug Reactions in Patients Undergoing Percutaneous Coronary Intervention
Pettersen, Trond
Allore, Heather
Bendz, Bjorn
Borregaard, Britt
Fridlund, Bengt
Ghaderi, Sara
Larsen, Alf Inge
Nordrehaug, Jan Erik
Rasmussen, Trine B.
Rotevatn, Svein
Schjott, Jan
CIRCULATION, 2021, 144
[42] Long-Term Aspirin and Clopidogrel Response Evaluated by Light Transmission Aggregometry, VerifyNow, and Thrombelastography in Patients Undergoing Percutaneous Coronary Intervention
Madsen, Esben Hjorth
Saw, Jacqueline
Kristensen, Soren Risom
Schmidt, Erik Berg
Pittendreigh, Cheryl
Maurer-Spurej, Elisabeth
CLINICAL CHEMISTRY, 2010, 56 (05) : 839 - 847
[43] Clopidogrel Resistance in Japanese Patients Scheduled for Percutaneous Coronary Intervention
Hoshino, Kozo
Horiuchi, Hisanori
Tada, Tomohisa
Tazaki, Junichi
Nishi, Eiichiro
Kawato, Mitsunori
Ikeda, Tomoyuki
Yamamoto, Hiromi
Akao, Masaharu
Furukawa, Yutaka
Shizuta, Satoshi
Toma, Masanao
Tamura, Toshihiro
Saito, Naritatsu
Doi, Takahiro
Ozasa, Neiko
Jinnai, Toshikazu
Takahashi, Kanako
Watanabe, Haruyo
Yoshikawa, Yuka
Nishimoto, Naoko
Ouchi, Chiho
Morimoto, Takeshi
Kita, Toru
Kimura, Takeshi
CIRCULATION JOURNAL, 2009, 73 (02) : 336 - 342
[44] Prevalence and temporal changes of aspirin and clopidogrel resistance in patients undergoing drug-eluting stent implantation: An evaluation from the clopidogrel and aspirin resistance evaluation in patients undergoing coronary revascularization (CARE-PCR) registry.
Park, S. W.
Park, D. W.
Suh, J.
Jung, J. H.
Kim, S. H.
Kim, Y. H.
Lee, C. W.
Hong, M. K.
Kinz, J. J.
Park, S. J.
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 92F - 93F
[45] Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions
Beitelshees, A. L.
Horenstein, R. B.
Vesely, M. R.
Mehra, M. R.
Shuldiner, A. R.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 455 - 459
[46] EVALUATION OF RESPONSE TO LOADING DOSES OF CLOPIDOGREL THERAPY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)
Saade, K.
El-hamamsy, M.
Hamdy, M.
Magdy, A.
VALUE IN HEALTH, 2012, 15 (04) : A114 - A115
[47] Dual Antiplatelet Therapy Resistance to Aspirin and Clopidogrel Identifies Patients at the Highest Risk of Recurrent Atherothrombotic Events After Percutaneous Coronary Intervention
Breet, Nicoline J.
van Werkum, Jochem W.
Bouman, Heleen J.
Kelder, Johannes C.
Hackeng, Christian M.
ten Berg, Jurrien M.
CIRCULATION, 2010, 122 (21)
[48] Reduced Anti-Platelet Response to Clopidogrel In Diabetic Patients Undergoing Percutaneous Coronary Intervention
Saucedo, Jorge
Singla, Anand
Mauer, Karin
Bliden, Kevin P.
Antonino, Mark J.
Yadav, Sunny
Hamed, Miruais
Hennebry, Thomas
Gurbel, Paul A.
CIRCULATION, 2008, 118 (18) : S819 - S819
[49] Clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention
Lin, Gen-Min
Li, Yi-Hwei
Chu, Kai-Min
Han, Chih-Lu
HEART, 2011, 97 (13) : 1111 - 1111
[50] Correction to: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention
Nejat Mahdieh
Ahmad Rabbani
Ata Firouzi
Ali Zahedmehr
Maryam Hoseinimoghaddam
Sedigheh Saedi
Hamidreza Sanati
Hosseinali Basiri
Feridoun Noohi
Bahareh Rabbani
Majid Maleki
Cardiovascular Toxicology, 2018, 18 : 492 - 492

← 1 2 3 4 5 →